Order Article Reprints

Sokol MB, Beganovskaya VA, Mollaeva MR, Yabbarov NG, Chirkina MV, Belykh DV, Startseva OM, Egorov AE, Kostyukov AA, Kuzmin VA, et al. Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative. Pharmaceutics. 2024; 16(1):126. https://doi.org/10.3390/pharmaceutics16010126

Sokol, Maria B., Veronika A. Beganovskaya, Mariia R. Mollaeva, Nikita G. Yabbarov, Margarita V. Chirkina, Dmitry V. Belykh, Olga M. Startseva, Anton E. Egorov, Alexey A. Kostyukov, Vladimir A. Kuzmin, and et al. 2024. "Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative" Pharmaceutics 16, no. 1: 126. https://doi.org/10.3390/pharmaceutics16010126

Sokol, M. B., Beganovskaya, V. A., Mollaeva, M. R., Yabbarov, N. G., Chirkina, M. V., Belykh, D. V., Startseva, O. M., Egorov, A. E., Kostyukov, A. A., Kuzmin, V. A., Lomakin, S. M., Shilkina, N. G., Krivandin, A. V., Shatalova, O. V., Gradova, M. A., Abakumov, M. A., Nikitin, A. A., Maksimova, V. P., Kirsanov, K. I., & Nikolskaya, E. D. (2024). Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative. Pharmaceutics, 16(1), 126. https://doi.org/10.3390/pharmaceutics16010126